What Insurance Companies Cover Prp Injections is a versatile approach used to address various medical conditions and injuries. Given the price tag of PRP injections, ranging from $800 to $2000 each, many patients hope that their insurance can assist in covering the costs. But the question remains: Does insurance cover PRP treatment? Let’s delve into the details.
PRP, or Platelet-Rich Plasma, involves concentrating platelets derived from a patient’s own blood. Practitioners of regenerative medicine administer PRP injections to enhance health and stimulate the body’s natural healing processes. The growth factors and other properties found in PRP can potentially aid in healing sports injuries, alleviating pain associated with osteoarthritis, and addressing concerns like wrinkles.
The Price of PRP Treatment
At present, the cost of PRP treatment can fluctuate significantly, ranging from approximately $800 to $2,000 for a single PRP injection. The total bill for your PRP therapy hinges on several factors, including the certification and expertise of the specialist performing the procedure, the geographic location where the therapy is conducted, the specific body area(s) being treated, and the quality of the PRP system employed to process and collect platelets.
Insurance Coverage for PRP
In many cases, insurance does not cover PRP treatment because several health insurance providers categorize PRP as an experimental therapy. Nevertheless, there are exceptions, with certain insurance companies offering coverage for PRP based on the specific medical condition or injury being treated. For instance, Tricare provides coverage for PRP injections to patients with tennis elbow and those suffering from mild to moderate chronic knee osteoarthritis. Some patients using WellCare Health Plans may also access PRP through participation in a study.
To ascertain whether your existing insurance plan covers PRP and to understand the specifics of that coverage, it is advisable to engage in a conversation with your insurance provider.
Medicare and Medicaid
The Centers for Medicare & Medicaid Services extend coverage for PRP exclusively to patients with “chronic non-healing diabetic, pressure, and/or venous wounds” who are concurrently enrolled in a clinical research study.
Securing Insurance Coverage for PRP
If your current insurance plan does not offer coverage for PRP, you have several potential options:
- Change Your Insurance Plan: Consider switching to an insurance plan that includes coverage for PRP treatments.
- Participate in a Study: Enrolling in a clinical research study may provide access to PRP.
- Advocate for Coverage: You can attempt to persuade your insurance company that PRP therapy is not experimental. This entails compiling relevant studies, reaching out to researchers, and constructing cost comparisons to support your case.
Read More : How Long Does Title Insurance Last
Understanding Insurance Codes
It is essential to communicate with both your physician and insurance provider regarding the insurance coding systems related to PRP treatments, as these codes impact billing and reimbursement. For instance, the CPT (Current Procedural Terminology) codes classify medical procedures and influence the charges you incur as a patient, as well as the compensation received by your healthcare provider.
CPT Category III code 0232T is applicable for the harvesting, preparation, and image-guided administration of PRP injections into various tissues. However, it may not be the correct code if additional treatments accompany the injections.
In the context of a clinical PRP study for Medicare, a Healthcare Common Procedure Coding System (HCPCS) code of G0460 is used, referring to the preparation and application of autologous PRP for ulcer treatment. HCPCS codes are specific to Medicare.
Reimbursement by Medicare contractors typically necessitates a billable ICD-10-CM code of Z00.6 and compliance with other criteria. ICD codes (International Classification of Diseases) are employed to identify diagnoses, and Z00.6 pertains to “a diagnosis of an encounter for examination for normal comparison and control in a clinical research program.”